Skip to main content

Natural Killer Cell Therapies Catch Up to CAR T

There’s a new cell-based cancer immunotherapy on the block.

Written byBianca Nogrady
| 10 min read

Register for free to listen to this article
Listen with Speechify
0:00
10:00

ABOVE: MODIFIED FROM © ISTOCK.COM, LARALOVA

When the first anticancer therapies based on engineered T cells hit the market a few years ago, they offered the possibility of what would have once been perceived as a medical miracle: a one-shot cure for certain blood cancers. Chimeric antigen receptor (CAR) T cell therapies, as they are known, involve harnessing the patient’s own immune cells, genetically modifying them with cancer-specific receptors for maximum potency against cancerous cells, then reinjecting them into the patient. But for all that cancer-fighting ability, CAR T cells come at a cost: potentially severe side effects, massive price tags, and slow manufacture.

Now a new cell therapy for cancer is edging into the spotlight. Natural killer (NK) cells have potential as a cellular anticancer therapy that could be significantly safer, cheaper, and faster, researchers say.

So far, NK cell therapies haven’t shown any of the significant toxicities that ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • head shot of smiling woman

    Bianca Nogrady is a freelance science journalist and author who is yet to meet a piece of research she doesn't find fascinating. In addition to The Scientist, her words have appeared in outlets including Nature, The Atlantic, Wired UK, The Guardian, Undark, MIT Technology Review, and the BMJ. She is also author of Climate Change: How We Can Get To Carbon Zero, The End: The Human Experience Of Death, editor of the 2019 and 2015 Best Australian Science Writing anthologies, and coauthor of The Sixth Wave: How To Succeed In A Resource-Limited World. She is based in Sydney, Australia.

    View Full Profile

Published In

April 2020

Exercise for Cancer

Molecular clues link physical activity to improved patient outcomes

Related Topics

November digest cover
November 2026

Chemistry Meets Arcade Combat in “Reaction Rumble” Game

Choose your fighter! Enter the arena as chemical elements and dole out moves inspired by real-world reactions in this educational browser-based game.

View this Issue
Thumbnail

Make It Local, Make It Last: The Evolution of mRNA Protein Replacement Therapy

Improving Western Blot Analysis of Biofluid Samples

Improving Western Blot Analysis of Biofluid Samples

Bio-Rad
Reducing AAV Sample Consumption With Multiwavelength SV-AUC

Reducing AAV Sample Consumption With Multiwavelength SV-AUC

​Beckman Coulter
Optimizing SV-AUC for Peptide Therapeutic Analysis

Optimizing SV-AUC for Peptide Therapeutic Analysis

​Beckman Coulter

Products

Sino Biological Logo

Sino Biological Advances AI-Designed Molecule Validation with 4RISE

Abstract image of circles and concentric lines on a blue and pink background.

MX Analytical and Precision Balances: Effortless Weighing and Secure Data Handling

Mettler
3D multicolored conceptual image of antibody molecules

Premium BsAb: LC-MS-Assisted Bispecific Antibody Production with >98% Heterodimer Purity

WuXi Biologics
Abstract conceptual image of AI technology for medical science research.

Exploring a New Era of Pharmaceutical Innovation